Pharmacists in Monsey, NY Accepting Medicare

10 Pharmacists found. Showing 1 - 10

Alex Yampolsky, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Route 306, Monsey, NY 10952 Phone: 845-362-8373

Ms. Shirin Rahmati, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 455 Route 306 Ste L, Monsey, NY 10952 Phone: 845-362-8373

Mrs. Blanche Reiss, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6 Woodcrest Rd, Monsey, NY 10952 Phone: 845-354-0473    Fax: 845-354-0472

Kimberly Xie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Route 59, Monsey, NY 10952 Phone: 845-371-6464    Fax: 845-213-4130

Mina Chapler Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42 Main St, Monsey, NY 10952 Phone: 845-356-9300

Israel Gottlieb Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 59 Route 59 Ste 143, Monsey, NY 10952 Phone: 845-425-3400    Fax: 845-213-4130

Mr. Dominic Esposito Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 42 Main St, Greenbaum's Pharmacy, Monsey, NY 10952 Phone: 845-356-9300    Fax: 845-356-7164

Dr. Carol R Smilow, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 27 Orchard St., Suite 111, Monsey, NY 10952 Phone: 845-356-3045    Fax: 845-356-3108

Mr. Eugene Frenkel, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 108b Route 59, Maple Pharmacy, Monsey, NY 10952 Phone: 845-371-6464    Fax: 845-371-5454

Mr. Steven Becker, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 45 Route 59, Monsey, NY 10952 Phone: 845-352-5666    Fax: 845-426-0559

News Archive

Israel's Ministry of Health approves Medgenics' INFRADURE Phase I/II clinical trials for hepatitis C

Medgenics, Inc., the developer of Biopump, a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that Israel's Ministry of Health (MOH) has approved two Phase I/II clinical trials to assess the safety and efficacy of INFRADURE in patients with hepatitis C.

Cappella commences evaluation of the Sideguard Coronary Sidebranch Stent & Delivery System

Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.

Quest Diagnostics intends to offer $750,000,000 senior notes in public offering

Quest Diagnostics Incorporated (the "Company") (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $750,000,000 in aggregate principal amount in two series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.

Excessive blood clotting and stroke in COVID-19 patients

The coronavirus disease COVID-19 is causing excessive blood clotting and stroke in young and healthy people, a new study has found.

Read more Medical News

› Verified 2 days ago